BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9809976)

  • 1. The role for NES1 serine protease as a novel tumor suppressor.
    Goyal J; Smith KM; Cowan JM; Wazer DE; Lee SW; Band V
    Cancer Res; 1998 Nov; 58(21):4782-6. PubMed ID: 9809976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression.
    Liu XL; Wazer DE; Watanabe K; Band V
    Cancer Res; 1996 Jul; 56(14):3371-9. PubMed ID: 8764136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization and mapping of the normal epithelial cell-specific 1 gene.
    Luo L; Herbrick JA; Scherer SW; Beatty B; Squire J; Diamandis EP
    Biochem Biophys Res Commun; 1998 Jun; 247(3):580-6. PubMed ID: 9647736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer.
    Dhar S; Bhargava R; Yunes M; Li B; Goyal J; Naber SP; Wazer DE; Band V
    Clin Cancer Res; 2001 Nov; 7(11):3393-8. PubMed ID: 11705853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue.
    Luo LY; Rajpert-De Meyts ER; Jung K; Diamandis EP
    Br J Cancer; 2001 Jul; 85(2):220-4. PubMed ID: 11461080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease.
    Yousef GM; Luo LY; Scherer SW; Sotiropoulou G; Diamandis EP
    Genomics; 1999 Dec; 62(2):251-9. PubMed ID: 10610719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The normal epithelial cell-specific 1 (NES1) gene is up-regulated by steroid hormones in the breast carcinoma cell line BT-474.
    Luo LY; Grass L; Diamandis EP
    Anticancer Res; 2000; 20(2A):981-6. PubMed ID: 10810385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
    Xia W; Unger P; Miller L; Nelson J; Gelman IH
    Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human kallikrein 10, a predictive marker for breast cancer.
    Zhang Y; Bhat I; Zeng M; Jayal G; Wazer DE; Band H; Band V
    Biol Chem; 2006 Jun; 387(6):715-21. PubMed ID: 16800732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer.
    Sprenger CC; Damon SE; Hwa V; Rosenfeld RG; Plymate SR
    Cancer Res; 1999 May; 59(10):2370-5. PubMed ID: 10344746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family.
    Yousef GM; Scorilas A; Diamandis EP
    Genomics; 2000 Jan; 63(1):88-96. PubMed ID: 10662548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4.
    Yousef GM; Luo LY; Diamandis EP
    Anticancer Res; 1999; 19(4B):2843-52. PubMed ID: 10652563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
    Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
    Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer.
    Yousef GM; Magklara A; Diamandis EP
    Genomics; 2000 Nov; 69(3):331-41. PubMed ID: 11056051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice.
    Vijayakumar S; Garcia D; Hensel CH; Banerjee M; Bracht T; Xiang R; Kagan J; Naylor SL
    Genes Chromosomes Cancer; 2005 Dec; 44(4):365-72. PubMed ID: 16080199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
    Jackson JG; Zhang X; Yoneda T; Yee D
    Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.